{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:50:17Z","timestamp":1777596617449,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.jbspin.2014.02.009","type":"journal-article","created":{"date-parts":[[2014,4,2]],"date-time":"2014-04-02T05:19:16Z","timestamp":1396415956000},"page":"398-402","source":"Crossref","is-referenced-by-count":19,"title":["The concept of the inflammasome and its rheumatologic implications"],"prefix":"10.1016","volume":"81","author":[{"given":"Alexander","family":"So","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Busso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2014.02.009_bib0005","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","article-title":"The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta","volume":"10","author":"Martinon","year":"2002","journal-title":"Mol Cell"},{"key":"10.1016\/j.jbspin.2014.02.009_bib0010","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jbspin.2010.11.004","article-title":"Interleukin-1beta activation during acute joint inflammation: a limited role for the NLRP3 inflammasome in vivo","volume":"78","author":"Joosten","year":"2011","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2014.02.009_bib0015","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/ar2143","article-title":"A pilot study of IL-1 inhibition by anakinra in acute gout","volume":"9","author":"So","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2014.02.009_bib0020","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/acr.21989","article-title":"Treatment of acute gouty arthritis in complex hospitalized patients with anakinra","volume":"65","author":"Ghosh","year":"2013","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jbspin.2014.02.009_bib0025","doi-asserted-by":"crossref","first-page":"R123","DOI":"10.1186\/ar4303","article-title":"Efficacy of anakinra in gouty arthritis: a retrospective study of 40 cases","volume":"15","author":"Ottaviani","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2014.02.009_bib0030","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1002\/acr.21690","article-title":"Rilonacept (interleukin-1 trap) for prevention of gout flares during initiation of uric acid-lowering therapy: Results from a phase III randomized, double-blind, placebo-controlled, confirmatory efficacy study","volume":"64","author":"Schumacher","year":"2012","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jbspin.2014.02.009_bib0035","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1136\/ard.2009.108936","article-title":"The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study","volume":"68","author":"Terkeltaub","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2014.02.009_bib0040","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1002\/art.27600","article-title":"Canakinumab for the treatment of acute flares in difficult-to-treat gouty arthritis: Results of a multicenter, phase II, dose-ranging study","volume":"62","author":"So","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2014.02.009_bib0045","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1136\/ard.2010.144063","article-title":"Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study","volume":"70","author":"Schlesinger","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2014.02.009_bib0050","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jbspin.2009.01.001","article-title":"Anakinra is a possible alternative in the treatment and prevention of acute attacks of pseudogout in end-stage renal failure","volume":"76","author":"Announ","year":"2009","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2014.02.009_bib0055","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jbspin.2012.07.018","article-title":"Efficacy of anakinra in calcium pyrophosphate crystal-induced arthritis: a report of 16 cases and review of the literature","volume":"80","author":"Ottaviani","year":"2013","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2014.02.009_bib0060","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jbspin.2012.01.010","article-title":"Efficacy of anakinra for refractory acute calcium pyrophosphate crystal arthritis","volume":"79","author":"Molto","year":"2012","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2014.02.009_bib0065","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1136\/annrheumdis-2012-202380","article-title":"A pilot study of IL-1 inhibition in acute calcific periarthritis of the shoulder","volume":"72","author":"Zufferey","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2014.02.009_bib0070","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1002\/art.27667","article-title":"Engagement of fatty acids with Toll-like receptor 2 drives interleukin-1beta production via the ASC\/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis","volume":"62","author":"Joosten","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2014.02.009_bib0075","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1136\/annrheumdis-2011-201215","article-title":"Purine-rich foods intake and recurrent gout attacks","volume":"71","author":"Zhang","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2014.02.009_bib0080","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0140-6736(04)16000-5","article-title":"Alcohol intake and risk of incident gout in men: a prospective study","volume":"363","author":"Choi","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2014.02.009_bib0085","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev.immunol.25.022106.141627","article-title":"Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease","volume":"27","author":"Masters","year":"2009","journal-title":"Ann Rev Immunol"},{"key":"10.1016\/j.jbspin.2014.02.009_bib0090","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1084\/jem.20082481","article-title":"In vivo regulation of interleukin 1beta in patients with cryopyrin-associated periodic syndromes","volume":"206","author":"Lachmann","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.jbspin.2014.02.009_bib0095","doi-asserted-by":"crossref","first-page":"9789","DOI":"10.1073\/pnas.1000779107","article-title":"Altered redox state of monocytes from cryopyrin-associated periodic syndromes causes accelerated IL-1beta secretion","volume":"107","author":"Tassi","year":"2010","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.jbspin.2014.02.009_bib0100","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1056\/NEJM200306193482523","article-title":"Interleukin-1-receptor antagonist in the Muckle-Wells syndrome","volume":"348","author":"Hawkins","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2014.02.009_bib0105","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1136\/ard.2004.032060","article-title":"Successful treatment of acute visual loss in Muckle-Wells syndrome with interleukin 1 receptor antagonist","volume":"64","author":"Alexander","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2014.02.009_bib0110","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa0810787","article-title":"Use of canakinumab in the cryopyrin-associated periodic syndrome","volume":"360","author":"Lachmann","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2014.02.009_bib0115","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1002\/art.23687","article-title":"Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies","volume":"58","author":"Hoffman","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2014.02.009_bib0120","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0140-6736(04)17401-1","article-title":"Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist","volume":"364","author":"Hoffman","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2014.02.009_bib0125","article-title":"Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review","author":"Ter Haar","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2014.02.009_bib0130","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1084\/jem.20050473","article-title":"Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade","volume":"201","author":"Pascual","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.jbspin.2014.02.009_bib0135","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1136\/ard.2009.108068","article-title":"IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still's disease","volume":"69","author":"Naumann","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2014.02.009_bib0140","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1136\/annrheumdis-2011-200743","article-title":"Anakinra treatment of SAPHO syndrome: short-term results of an open study","volume":"71","author":"Wendling","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2014.02.009_bib0145","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1398-9995.2012.02843.x","article-title":"Efficacy and safety of the interleukin-1 antagonist rilonacept in Schnitzler syndrome: an open-label study","volume":"67","author":"Krause","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.jbspin.2014.02.009_bib0150","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1600-065X.2008.00643.x","article-title":"How the study of children with rheumatic diseases identified interferon-alpha and interleukin-1 as novel therapeutic targets","volume":"223","author":"Pascual","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jbspin.2014.02.009_bib0155","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1056\/NEJMoa1205099","article-title":"Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis","volume":"367","author":"Ruperto","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2014.02.009_bib0160","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/acr.21901","article-title":"Anakinra in adult-onset still's disease: long-term treatment in patients resistant to conventional therapy","volume":"65","author":"Giampietro","year":"2013","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jbspin.2014.02.009_bib0165","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kep222","article-title":"Dysfunctional inflammasome in Schnitzler's syndrome","author":"Pizzirani","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2014.02.009_bib0170","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1684\/ecn.2009.0164","article-title":"Free circulating interleukin-18 is increased in Schnitzler syndrome: a new autoinflammatory disease?","volume":"20","author":"Migliorini","year":"2009","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.jbspin.2014.02.009_bib0175","doi-asserted-by":"crossref","first-page":"i81","DOI":"10.1136\/ard.59.suppl_1.i81","article-title":"Arguments for interleukin 1 as a target in chronic arthritis","volume":"59","author":"van den Berg","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2014.02.009_bib0180","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.4049\/jimmunol.179.7.4867","article-title":"Deficiency of the NF-kappaB inhibitor caspase activating and recruitment domain 8 in patients with rheumatoid arthritis is associated with disease severity","volume":"179","author":"Fontalba","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.jbspin.2014.02.009_bib0185","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/rheumatology\/kem372","article-title":"Genetic variation in proteins of the cryopyrin inflammasome influences susceptibility and severity of rheumatoid arthritis (the Swedish TIRA project)","volume":"47","author":"Kastbom","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2014.02.009_bib0190","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1136\/ard.2008.106989","article-title":"CARD8 p.C10X polymorphism is associated with inflammatory activity in early rheumatoid arthritis","volume":"69","author":"Kastbom","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2014.02.009_bib0195","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1744-313X.2011.01070.x","article-title":"Association study of CARD8 (p.C10X) and NLRP3 (p.Q705K) variants with rheumatoid arthritis in French and Tunisian populations","volume":"39","author":"Ben Hamad","year":"2012","journal-title":"Int J Immunogenet"},{"key":"10.1016\/j.jbspin.2014.02.009_bib0200","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.4049\/jimmunol.0802173","article-title":"Inflammatory role of ASC in antigen-induced arthritis is independent of caspase-1. NALP-3, and IPAF","volume":"183","author":"Kolly","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jbspin.2014.02.009_bib0205","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s00296-011-1825-y","article-title":"ASC plays a role in the priming phase of the immune response to type II collagen in collagen-induced arthritis","volume":"32","author":"Yamazaki","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jbspin.2014.02.009_bib0210","doi-asserted-by":"crossref","first-page":"15122","DOI":"10.1074\/jbc.M412284200","article-title":"ASC-mediated NF-kappaB activation leading to interleukin-8 production requires caspase-8 and is inhibited by CLARP","volume":"280","author":"Hasegawa","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jbspin.2014.02.009_bib0215","doi-asserted-by":"crossref","first-page":"7655","DOI":"10.4049\/jimmunol.0800448","article-title":"Mechanism and repertoire of ASC-mediated gene expression","volume":"182","author":"Hasegawa","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jbspin.2014.02.009_bib0220","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1365-2567.2009.03174.x","article-title":"Expression and function of the NALP3 inflammasome in rheumatoid synovium","volume":"129","author":"Kolly","year":"2010","journal-title":"Immunology"},{"key":"10.1016\/j.jbspin.2014.02.009_bib0225","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/art.24096","article-title":"Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study","volume":"61","author":"Chevalier","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2014.02.009_bib0230","doi-asserted-by":"crossref","first-page":"14867","DOI":"10.1073\/pnas.1111101108","article-title":"NLRP3 inflammasome plays a critical role in the pathogenesis of hydroxyapatite-associated arthropathy","volume":"108","author":"Jin","year":"2011","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.jbspin.2014.02.009_bib0235","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1002\/art.34678","article-title":"Stress-induced cartilage degradation does not depend on the NLRP3 inflammasome in human osteoarthritis and mouse models","volume":"64","author":"Bougault","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2014.02.009_bib0240","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3109\/08916934.2011.637532","article-title":"Polimorphisms in inflammasome genes are involved in the predisposition to systemic lupus erythematosus","volume":"45","author":"Pontillo","year":"2012","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jbspin.2014.02.009_bib0245","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.molimm.2011.08.022","article-title":"Cell type and gender-dependent differential regulation of the p202 and Aim2 proteins: implications for the regulation of innate immune responses in SLE","volume":"49","author":"Panchanathan","year":"2011","journal-title":"Mol Immunol"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X14000530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X14000530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T03:49:33Z","timestamp":1597636173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X14000530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S1297319X14000530"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2014.02.009","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]}}}